3
Views
1
CrossRef citations to date
0
Altmetric
Review

Medicated intrauterine devices for contraception and their therapeutic effects

&
Pages 195-202 | Published online: 10 Jan 2014
 

Abstract

There is currently one medicated intrauterine device on the market for clinical use; Mirena®, which releases levonorgestel. Mirena has widely replaced Progestasert®, which released progesterone. The levonorgestel released by Mirena into the uterine cavity not only increases the contraceptive efficacy of the intrauterine device but also has many beneficial effects on women’s health. This article reviews the contraceptive efficacy of this medicated intrauterine device, the health effects of progestin delivered onto the endometrial surface and its therapeutic use in clinical practice.

Acknowledgements

We are grateful to Nicholas Bolton for his expert language revision of this review. We are deeply grateful to The Ford Foundation for their support over the past 15 years, which has made independent developmental work possible; to the US Agency for International Development and to The Population Council (NY, USA) for support; and to the Council’s International Committee fo Contraceptive Research and Family Health International (NC, USA) for cooperation and intellectual support.

Log in via your institution

Log in to Taylor & Francis Online

There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.